Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

2006 ◽  
Vol 54 (3) ◽  
pp. 702-710 ◽  
Author(s):  
Josef S. Smolen ◽  
Désirée M. F. M. Van Der Heijde ◽  
E. William St.Clair ◽  
Paul Emery ◽  
Joan M. Bathon ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Early Rheumatoid Arthritis ◽  
Joint Damage ◽  
High Dose ◽  
High Dose Methotrexate ◽  
Dose Methotrexate

scholarly journals Effect of subcutaneous high-dose methotrexate treatment on the management of rheumatoid arthritis

2021 ◽  
Vol 46 (3) ◽  
pp. 1150-1159
Author(s):  
Müge AYDIN TUFAN ◽  
Emine ERSÖZLÜ BOZKIRLI ◽  
Hamide KART ◽  
Ahmet YÜCEL
Keyword(s):  
Rheumatoid Arthritis ◽  
High Dose ◽  
High Dose Methotrexate ◽  
Dose Methotrexate ◽  
Methotrexate Treatment

scholarly journals Toxicity Due to High Dose Methotrexate In A Patient With Rheumatoid Arthritis: Case Report

2017 ◽  
Vol 24 (4) ◽  
pp. 378-381
Author(s):  
Ali Doğan ◽  
Ömer Ekinci ◽  
İsmet Kızılkaya ◽  
Ergin Turgut ◽  
Mehmet Maruf Kayran ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Case Report ◽  
High Dose ◽  
High Dose Methotrexate ◽  
Rheumatoid Arthritis Case ◽  
Dose Methotrexate
Sign in / Sign up

Export Citation Format

Share Document